MSTR stock holds premium as Saylor issues preferreds

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="wrapper-sevio-e97c3304-a262-4b2a-8dd5-796490b4dc7c"] { width: 320px; height: 100px; } } @media only screen and (min-width: 728px) and (min-height: 0px) { div[id^="wrapper-sevio-e97c3304-a262-4b2a-8dd5-796490b4dc7c"] { width: 728px; height: 90px; } }

window.sevioads = window.sevioads || []; var sevioads_preferences = []; sevioads_preferences[0] = {}; sevioads_preferences[0].zone = "e97c3304-a262-4b2a-8dd5-796490b4dc7c"; sevioads_preferences[0].adType = "banner"; sevioads_preferences[0].inventoryId = "17b11a0e-c9a7-4ab0-9788-1941464500f3"; sevioads_preferences[0].accountId = "ad82357c-af89-4cb2-ad76-470425cadd81"; sevioads.push(sevioads_preferences);

Yes, Michael Saylor is signaling more Bitcoin buys: current evidence

Michael Saylor has renewed speculation about further Bitcoin (BTC) accumulation by posting “The Turn of the Century,” alongside his closely watched orange dot chart that traders often interpret as a buying clue. That visual signal has repeatedly been read as a precursor to new purchases by MicroStrategy (MSTR).

There is also fresh transaction evidence. MicroStrategy added roughly 592 BTC in late February 2026 even as broader crypto and equity markets were under pressure, reinforcing the company’s pattern of buying into weakness.

How MicroStrategy funds buys: preferred stock issuance, convertibles, ATM program

Recent coverage indicates the company has leaned on multiple financing channels to extend its accumulation strategy. One lever has been issuing sizable amounts of preferred stock, a tactic used to offset performance drag when Bitcoin weakens. In parallel, MicroStrategy has historically used other capital markets tools that can be deployed opportunistically.

After reiterating the company’s accumulation stance, Michael Saylor also addressed liquidity and payout capacity. “We will continue buying Bitcoin each quarter forever,” said Michael Saylor, executive chairman, in a February 2026 interview. In the same discussion, he indicated the company had sufficient cash to handle debt and preferred dividends for an extended period, even in a down market, underscoring management’s view that ongoing issuance is not the only liquidity backstop.

Convertible notes have also featured in the playbook during prior waves of accumulation. A 2025 financing round via convertibles coincided with the purchase of more than 20,000 additional BTC, illustrating how the company has paired liability issuance with incremental coin buys. Beyond preferreds and convertibles, an at-the-market (ATM) equity program provides flexibility to raise cash in smaller tranches as market windows open. At the time of this writing, MSTR last traded near $129.72 per share based on Nasdaq real-time pricing, offering context for the potential capacity of any such programs.

Implications for MSTR stock: dilution, NAV premium, and risk signals

The principal near-term trade-off is dilution versus balance-sheet optionality. Cantor Fitzgerald recently highlighted the narrowing gap between MicroStrategy’s market value and its Bitcoin net-asset value (mNAV) while cutting its 12‑month target for the stock, framing premium compression as a material risk if capital markets become less receptive to new issuance.

Caution is also building on the funding side. Monness, Crespi, Hardt warned that the most relied-upon channels, equity and preferreds, could face limits, which would challenge the cadence of future accumulation and raise sensitivity to any drawdown in the share price or BTC.

Skeptics argue that the model’s success depends on sustained market access and a supportive premium to underlying BTC holdings. Economist Peter Schiff has criticized the strategy’s reliance on continual capital raises, contending that it could prove fragile in a prolonged downturn. In practice, investors are watching three signals most closely: the frequency of new capital raises, the persistence of the mNAV premium, and whether BTC weakness starts to coincide with higher-than-expected dilution.